Agentic AI
Brain-tech startup Science Corporation valued at $3.5B with $400M funding round
Max Hodak's neurotech company closes Series D as it scales its vision-restoration implant and prepares for human trials of a hybrid brain sensor.
TechCrunch — AI
Science Corporation, the neurotech venture founded by former Neuralink president Max Hodak, has completed a $400 million Series D funding round that values the company at $3.5 billion. The investment was led by backers including Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.
Hodak launched Science in 2021 with the goal of developing technologies that enable the brain to be better understood and interfaced with. His path to founding the company began unconventionally: he talked his way into a neuroscience lab while still an undergraduate, launching a career focused on biotechnology and brain-machine interfaces.
Current product: PRIMA for vision restoration#
The company's initial offering is PRIMA, a device that combines wearable and implantable components to assist people with age-related macular degeneration in regaining vision. The technology has already received regulatory approval and is currently available to patients in Germany, with trials underway across Europe for additional applications.
Recently, Hodak announced that PRIMA is being tested in patients with Stargardt's disease, another major cause of blindness, marking an expansion of the device's clinical scope.
FDA pathway and US expansion#
Science plans to bring PRIMA to the United States by seeking approval through the FDA's Humanitarian Device Exemption program, a regulatory pathway designed for investigational medical devices targeting rare conditions. The company has successfully argued to the FDA that bilateral advanced macular degeneration is sufficiently uncommon to qualify for this streamlined review process.
Next frontier: brain-computer interface#
Beyond the vision device, Science's larger ambition centers on developing a bio-hybrid brain sensor — a component that merges cultured neurons with silicon technology to create a direct link with the human brain. The company is currently designing the protocol for initial human trials in collaboration with Yale neurosurgery professor Murat Günel, who has indicated the technology could eventually address conditions including Parkinson's disease and other neurological injuries and disorders.

